Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Solna, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Aging (Albany NY). 2020 May 22;12(11):10147-10161. doi: 10.18632/aging.103315.
A major challenge in the health care system is the lack of knowledge about the possible harmful effects of multiple drug treatments in old age. The present study aims to characterize a mouse model of polypharmacy, in order to investigate whether long-term exposure to multiple drugs could lead to adverse outcomes. To this purpose we selected five drugs from the ten most commonly used by older adults in Sweden (metoprolol, paracetamol, aspirin, simvastatin and citalopram). Five-month-old wild type male mice were fed for eight weeks with control or polypharmacy diet. We report for the first time that young adult polypharmacy-treated mice showed a significant decrease in exploration and spatial working memory compared to the control group. This memory impairment was further supported by a significant reduction of synaptic proteins in the hippocampus of treated mice. These novel results suggest that already at young adult age, use of polypharmacy affects explorative behavior and synaptic functions. This study underlines the importance of investigating the potentially negative outcomes from concomitant administration of different drugs, which have been poorly explored until now. The mouse model proposed here has translatable findings and can be applied as a useful tool for future studies on polypharmacy.
医疗体系面临的一个主要挑战是,人们对老年人接受多种药物治疗可能产生的有害影响知之甚少。本研究旨在构建一种多药治疗的小鼠模型,以研究长期接受多种药物治疗是否会导致不良后果。为此,我们从瑞典老年人最常使用的十种药物中选择了五种(美托洛尔、对乙酰氨基酚、阿司匹林、辛伐他汀和西酞普兰)。将五个月大的野生型雄性小鼠用对照或多药饮食喂养八周。我们首次报道称,与对照组相比,接受多药治疗的年轻成年小鼠表现出明显的探索和空间工作记忆减退。在接受治疗的小鼠的海马体中,突触蛋白的显著减少进一步支持了这一记忆损伤。这些新的结果表明,即使在成年早期,多药治疗的使用也会影响探索行为和突触功能。本研究强调了研究同时使用不同药物可能产生的潜在负面影响的重要性,迄今为止,这方面的研究还很少。本研究提出的小鼠模型具有可转化的研究结果,可作为未来多药治疗研究的有用工具。